Gut Microbiota in Neurologic and Visceral Diseases

Ayurveda Diabetes Brain Aging Environment Inflammation Insulin resistance. Multiple Sclerosis Neurotransmitters Stroke Cardiovascular Diseases Parkinson's disease Cytokines Dopamine Metabolic syndrome Multiple organ failure Oxidative stress Tempeh Chemokines Essential fatty acids Amyotrophic lateral sclerosis Pesticides Bile acids Dopaminergic neurons Glucagon-like peptide 1 Huntington's Disease Prebiotics Probiotics Neurogenic Inflammation kefir Microbiota Alzheimer's disease Betaine Dysbiosis Non-alcoholic fatty liver disease Modulation Type 2 diabetes TMAO Microbiome Short Chain Fatty Acids Innate immunity Herbal Formulations Neuroinflammation Neurodevelopment Prebiotic Gut-brain axis Central nervous system (CNS) Peptide YY Neurodegeneration Clostridium difficile Mitochondrial Dysfunction Nitrosative stress Cardiovascular Disease Gut microbiota Probiotic Migraine Headache Acute respiratory distress syndrome (ARDS) Neurological Disorders Fiber Metabolic disorders Bioactive Lipids Western Diet covid-19 Bioactive peptides Choline Microbiota-gut-brain-axis antiinflammation Angiotensin-converting enzyme 2 aryl hydrocarbon receptor (AhR) Cerebral vasodilation a-synuclein Cardiometabolic diseases Disruption of BBB cortical spreading depression Farnesoid X receptor Fecal microbiota transplantation Enterotype Glucagon-like peptide 2 Fermented foods and beverages Gastric inhibitory polypeptide Edible bacteria Indole pathway Lewy bodies Mediterranean diet Kynurenine pathway Fecal microbial transplantation Microbiome modulators Neurotoxicants Nattokinase S-proteins Vascular dysfunction Sleep disturbance Quinolinic acid Western diet obesity Tryptophan metabolites vagal Visceral diseases Trimethylamine oxide